X

Solvay Pharma India Ltd. (Amalgamated) Stock Analysis

Small Cap
Evaluated by 109 users | BSE: 532447 | NSE: |
Pharmaceuticals & Drugs
Solvay Pharma India (SPIL) was incorporated in 2002 as a consequence of the demerger of pharma business of Duphar-Interfran. Solvay Pharma India has presence in the field of women’s health, gastroenterology, mental health and influenza vaccines. Deeply rooted in these specialty segments...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'02Dec'02Dec'03Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10
Return on Capital Employed 49.77%34.49%25.71%39%29.21%25.15%32.91%32.88%32.54%33.97%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 78.182.396.6116130144168200242295
Y-o-Y Gr. Rt.-5.3%17.4%20.3%11.7%11.1%16.4%19.4%20.7%21.9%
Adjusted EPS (Rs.) 15.8720.9315.5134.3235.1337.2954.9963.8277.1399.54
Y-o-Y Gr. Rt.-31.9%-25.9%121.3%2.4%6.2%47.5%16.1%20.9%29.1%
Book Value per Share (Rs.) 39.6469.864.7105.31134.55162.51171.89216.38257.62328.59
Adjusted Net Profit 810.67.817.317.718.827.832.23950.3
Net Op. Cash Flow (Rs. Cr.) 1020.1-2.321.517.314.726.6-6.769.727.5
Debt to Cash Flow from Ops 00-1.460.010.0100000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Solvay Pharma India Ltd. (Amalgamated) should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 15.9%17.8%20.7%21.9%
Adjusted EPS 22.6%23.2%21.9%29.1%
Book Value per Share 26.519.624.127.6
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'02Dec'02Dec'03Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10
Return on Equity (%) 48.634.1326.5140.3729.325.132.8932.8732.5433.96
Operating Profit Margin (%) 16.7120.0717.2823.7123.2521.5326.3423.4724.9124.85
Net Profit Margin (%) 10.2612.858.1114.9213.6813.0716.5516.0916.1117.06
Debt to Equity 000.10.01000000
Working Capital Days 77112959085959212111595
Cash Conversion Cycle 21173135252821313023
Entity Percentage Holding
Promoters 88.85%
Institutions 0.01%
Non-Institutions 11.14%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Solvay Pharma India (SPIL) was incorporated in 2002 as a consequence of the demerger of pharma business of Duphar-Interfran. Solvay Pharma India has presence in the field of women’s health, gastroenterology, mental health and influenza vaccines. Deeply rooted in these specialty segments SPIL is a leader with its competent products and innovative solutions. The company strives to provide the health care industry with newer & quality products that are effective and safe in areas

Solvay Pharma India (SPIL) was incorporated in 2002 as a consequence of the demerger of pharma business of Duphar-Interfran. Solvay Pharma India has presence in the field of women’s health, gastroenterology, mental health and influenza vaccines. Deeply rooted in these specialty segments SPIL is a leader with its competent products and innovative solutions. The company strives to provide the health care industry with newer & quality products that are effective and safe in areas where clinical need for treatment is most urgent.

Products

Women Health

  • arachitol®
  • duphaston®
  • duvadilan®
  • Utrogestan®
  • puregon*
  • nugon*
  • clome*
  • Oestrogel®
  • bcrip*

Psychiatry / ENT / Neurology

  • solspre*
  • vertin®
  • uvox*
  • ebasil*

Gastroenterology

  • duphalac®
  • creon®
  • colospa®
  • eldicet®
  • pankreoflat®
  • udiliv®

Vaccines

  • influvac®

General

  • duodil®
  • collosal iodine oral

Solvay is an international chemical and pharmaceutical group with headquarters in Brussels. In India, Solvay is present in the pharmaceutical sector through its group company Solvay Pharma India. The company is head quartered at Mumbai and employs more than 450 people throughout India. It operates through two sales divisions and reaches out to its customers across the country through more than 1100 distributors. Currently the company structures itself into 2 Divisions, aided with its dedicated sales force and focusing on specialties and super specialties.

With research as the backbone, most of the products are brand leaders in their respective therapeutic segments. High level of scientific interaction, intense product knowledge enables the team to meet the ever-changing needs of medicine. New Product Introduction is advocated actively and the company plans to launch new products each year in either divisions.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback